TYRA
Income statement / Annual
Last year (2023), Tyra Biosciences, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Tyra Biosciences, Inc.'s net income was -$69.13 M.
See Tyra Biosciences, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$353,000.00 |
$296,000.00 |
$140,000.00 |
$47,000.00 |
$8,000.00 |
| Gross Profit |
-$353,000.00 |
-$296,000.00 |
-$140,000.00 |
-$47,000.00 |
-$8,000.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$62.52 M
|
$43.01 M
|
$20.64 M
|
$7.20 M
|
$1.79 M
|
| General & Administrative
Expenses |
$17.43 M
|
$15.92 M
|
$5.65 M
|
$2.09 M
|
$1.33 M
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$17.43 M
|
$15.92 M
|
$5.65 M
|
$2.09 M
|
$1.33 M
|
| Other Expenses |
$0.00 |
-$50,000.00 |
-$19,000.00 |
-$23,000.00 |
-$8,000.00 |
| Operating Expenses |
$79.95 M |
$58.93 M |
$26.29 M |
$9.30 M |
$3.12 M |
| Cost And Expenses |
$79.95 M |
$58.93 M |
$26.29 M |
$9.30 M |
$3.12 M |
| Interest Income |
$10.85 M |
$3.65 M |
$13,000.00 |
$1.00 |
$1.00 |
| Interest Expense |
$0.00 |
$0.00 |
$0.00 |
$1,000.00 |
$1,000.00 |
| Depreciation &
Amortization |
$353,000.00
|
$296,000.00
|
$140,000.00
|
$47,000.00
|
$8,000.00
|
| EBITDA |
-$79.59 M
|
-$58.63 M
|
-$26.15 M
|
-$9.25 M
|
-$3.11 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
$10.81 M
|
$3.60 M
|
-$6,000.00
|
-$39,000.00
|
-$943,000.00
|
| Income Before Tax |
-$69.13 M |
-$55.33 M |
-$26.29 M |
-$9.34 M |
-$4.07 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
-$3.60 M |
-$153,000.00 |
-$22,000.00 |
-$7,000.00 |
| Net Income |
-$69.13 M |
-$51.72 M |
-$26.14 M |
-$9.31 M |
-$4.06 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
| EPS |
-1.62 |
-1.23 |
-0.63 |
-0.22 |
-0.0954 |
| EPS Diluted |
-1.62 |
-1.23 |
-0.63 |
-0.22 |
-0.0954 |
| Weighted Average Shares
Out |
$42.70 M
|
$41.88 M
|
$41.44 M
|
$42.54 M
|
$42.54 M
|
| Weighted Average Shares
Out Diluted |
$42.70 M
|
$41.88 M
|
$41.44 M
|
$42.54 M
|
$42.54 M
|
| Link |
|
|
|
|
|
